Search

everythinglearnresearchcommunity

for

Search:↓

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

CBD can either reduce inflammation and not affect hair growth at low levels or inhibit hair growth at high levels.

Adding amber particles to polyamide fibers makes them suitable for medical textiles like compression socks.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The apelinergic system might protect the heart from damage caused by doxorubicin.

Alopecia areata may be linked to imbalanced gut bacteria.

Stem cells from umbilical cord blood may prevent hair loss caused by certain medications.

Combining plasma rich in growth factors with hair transplant surgery may lead to faster recovery and better outcomes for hair loss treatment.

Direct excision techniques can rejuvenate the neck but may not enhance the jawline and could cause neck-face disharmony if done incorrectly.

Carbamazepine can cause hair loss, which may reverse when the medication is stopped.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

Possible link between androgens and COVID-19 severity; more research needed.

Men had worse COVID-19 outcomes than women in New York City.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

Researchers created small amber particles for use in bioactive and biocompatible fibers that could help with skin and hair restoration and are safe for infant clothing.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Polygonum multiflorum shows promise for treating Alzheimer's and cognitive impairments.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.